on this page
Since our inception in 2009, Biocytogen has maintained a strong focus on genetic engineering, leading to the creation of multiple mouse strains for preclinical efficacy testing and antibody drug discovery. More recently, our team has been dedicated to developing knockout mice for key drug target genes to facilitate mechanistic studies and target discovery. We are proud to introduce more than 800 new strains of gene knockout mice, now available for diverse animal model applications worldwide.
C57BL/6N-Hbb-bttm1Bcgen Hbb-bstm1Bcgen/Bcgen • 113046
NOD.CB17-Prkdcscid Il2rgtm1Bcgen B2mtm1Bcgen Fcgrttm1(B2m/Fcgrt)Bcgen H2-Ab1tm1Bcgen/Bcgen • 111895